tradingkey.logo

tradingkey.logo
怜玢


IQVIA Holdings Inc

IQV
りォッチリストに远加
178.710USD
+0.160+0.09%
終倀 05/08, 16:00ET15分遅れの株䟡
29.83B時䟡総額
22.00盎近12ヶ月PER


IQVIA Holdings Inc

178.710
+0.160+0.09%

詳现情報 IQVIA Holdings Inc 䌁業名

IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.

IQVIA Holdings Incの䌁業情報


䌁業コヌドIQV
䌚瀟名IQVIA Holdings Inc
䞊堎日May 09, 2013
最高経営責任者「CEO」Bousbib (Ari)
埓業員数88000
蚌刞皮類Ordinary Share
決算期末May 09
本瀟所圚地2400 Ellis Road
郜垂DURHAM
蚌刞取匕所NASDAQ OMX NASDAQ Basic NYSE
囜United States of America
郵䟿番号27703
電話番号19199982000
りェブサむトhttps://ir.iqvia.com/
䌁業コヌドIQV
䞊堎日May 09, 2013
最高経営責任者「CEO」Bousbib (Ari)

IQVIA Holdings Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Ari Bousbib
Mr. Ari Bousbib
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.41M
+2.04%
Mr. Ronald E. (Ron) Bruehlman
Mr. Ronald E. (Ron) Bruehlman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
65.53K
+14.55%
Mr. Eric M. Sherbet
Mr. Eric M. Sherbet
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
30.89K
+15.83%
Mr. John G. Danhakl
Mr. John G. Danhakl
Independent Director
Independent Director
30.32K
+5.25%
Dr. John M. Leonard, M.D.
Dr. John M. Leonard, M.D.
Lead Independent Director
Lead Independent Director
16.95K
+9.27%
Ms. Colleen A. Goggins
Ms. Colleen A. Goggins
Independent Director
Independent Director
14.45K
+10.87%
Ms. Carol J. Burt
Ms. Carol J. Burt
Independent Director
Independent Director
5.96K
--
Mr. Bhavik Patel
Mr. Bhavik Patel
President, Commercial Solutions
President, Commercial Solutions
3.03K
+71.48%
Mr. James A. Fasano
Mr. James A. Fasano
Independent Director
Independent Director
1.06K
--
Mr. John P. Connaughton
Mr. John P. Connaughton
Independent Director
Independent Director
1.05K
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Ari Bousbib
Mr. Ari Bousbib
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.41M
+2.04%
Mr. Ronald E. (Ron) Bruehlman
Mr. Ronald E. (Ron) Bruehlman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
65.53K
+14.55%
Mr. Eric M. Sherbet
Mr. Eric M. Sherbet
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
30.89K
+15.83%
Mr. John G. Danhakl
Mr. John G. Danhakl
Independent Director
Independent Director
30.32K
+5.25%
Dr. John M. Leonard, M.D.
Dr. John M. Leonard, M.D.
Lead Independent Director
Lead Independent Director
16.95K
+9.27%
Ms. Colleen A. Goggins
Ms. Colleen A. Goggins
Independent Director
Independent Director
14.45K
+10.87%

収益内蚳

通貚: USD曎新時刻: Mon, Apr 6
通貚: USD曎新時刻: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
䌚瀟から関連デヌタがただ開瀺されおいたせん。
地域別USD
䌚瀟名
収益
比率
Americas
7.75B
47.49%
Europe & Africa Region
5.18B
31.79%
Asia Pacific Region
3.38B
20.72%
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Sun, May 10
曎新時刻: Sun, May 10
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Harris Associates L.P.
6.78%
Vanguard Capital Management, LLC
6.61%
BlackRock Institutional Trust Company, N.A.
5.19%
Vanguard Portfolio Management, LLC
4.54%
State Street Investment Management (US)
4.46%
他の
72.42%
株䞻統蚈
株䞻統蚈
比率
Harris Associates L.P.
6.78%
Vanguard Capital Management, LLC
6.61%
BlackRock Institutional Trust Company, N.A.
5.19%
Vanguard Portfolio Management, LLC
4.54%
State Street Investment Management (US)
4.46%
他の
72.42%
皮類
株䞻統蚈
比率
Investment Advisor
48.99%
Investment Advisor/Hedge Fund
38.83%
Sovereign Wealth Fund
5.32%
Hedge Fund
2.94%
Pension Fund
2.82%
Research Firm
2.77%
Bank and Trust
2.23%
Individual Investor
1.00%
Family Office
0.16%

機関投資家保有株


曎新時刻: Sun, Apr 5
曎新時刻: Sun, Apr 5
報告期間
機関投資家数
保有株匏数
比率
倉動額
2026Q1
2209
173.06M
103.69%
-9.60M
2025Q4
2132
171.19M
100.94%
-15.17M
2025Q3
2061
175.98M
103.33%
-829.63K
2025Q2
2053
166.70M
98.05%
-9.45M
2025Q1
2083
168.53M
97.38%
-9.36M
2024Q4
2059
171.87M
97.45%
+3.00M
2024Q3
2008
173.01M
95.44%
+863.78K
2024Q2
1977
164.85M
90.43%
-7.68M
2024Q1
1950
165.50M
90.84%
-10.38M
2023Q4
1948
168.90M
93.03%
-6.38M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Harris Associates L.P.
11.32M
6.74%
-67.55K
-0.59%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
8.67M
5.16%
-772.77K
-8.18%
Dec 31, 2025
State Street Investment Management (US)
7.45M
4.44%
-102.01K
-1.35%
Dec 31, 2025
GIC Private Limited
6.54M
3.9%
-2.59M
-28.36%
Mar 31, 2025
Geode Capital Management, L.L.C.
4.37M
2.61%
+24.45K
+0.56%
Dec 31, 2025
Boston Partners
4.09M
2.43%
+530.67K
+14.92%
Dec 31, 2025
Artisan Partners Limited Partnership
3.37M
2.01%
-62.57K
-1.82%
Dec 31, 2025
AllianceBernstein L.P.
3.30M
1.97%
-293.54K
-8.16%
Dec 31, 2025
詳现を芋る

関連ETF


曎新時刻: Tue, Dec 2
曎新時刻: Tue, Dec 2
銘柄名
比率
First Trust Nasdaq Lux Digi Health Solutions ETF
9.1%
Langar Global HealthTech ETF
7.83%
Global X HealthTech ETF
5.5%
VanEck Biotech ETF
4.98%
iShares Biotechnology ETF
3.23%
iShares Health Innovation Active ETF
3.05%
Adaptive Core ETF
3.04%
Invesco Bloomberg Pricing Power ETF
2.24%
Running Oak Efficient Growth ETF
2.16%
Invesco Zacks Mid-Cap ETF
2.08%
詳现を芋る
First Trust Nasdaq Lux Digi Health Solutions ETF
比率9.1%
Langar Global HealthTech ETF
比率7.83%
Global X HealthTech ETF
比率5.5%
VanEck Biotech ETF
比率4.98%
iShares Biotechnology ETF
比率3.23%
iShares Health Innovation Active ETF
比率3.05%
Adaptive Core ETF
比率3.04%
Invesco Bloomberg Pricing Power ETF
比率2.24%
Running Oak Efficient Growth ETF
比率2.16%
Invesco Zacks Mid-Cap ETF
比率2.08%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
デヌタなし
日付
配圓萜ち日
皮類
比率
デヌタなし
KeyAI
î™